4-aminobiphenyl-DNA adducts and p53 mutations in bladder cancer

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 512-516

  Martone, Tiziana ^a   Airoldi, Luisa ^b   Magagnotti, Cinzia ^b   Coda, Renato ^c   Randone, Donato ^c   Malaveille, Christian ^d   Avanzi, Giancarlo ^a   Merletti, Franco ^a   Hautefeuille, Agnes ^d   Vineis, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c GRADENIGO HOSPITAL   (Italy)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE; ACYLTRANSFERASE; AROMATIC AMINE; DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CANCER; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TOBACCO; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AMINOBIPHENYL COMPOUNDS; ARYLAMINE N-ACETYLTRANSFERASE; DNA ADDUCTS; GENES, P53; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PLANTS, TOXIC; SMOKING; TOBACCO; URINARY BLADDER NEOPLASMS;

EID: 0032498595     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<512::AID-IJC4>3.0.CO;2-W     Document Type: Article

References (33)

1. ARMITAGE, P. and BERRY, G., Statistical methods in medical research. (2nd ed.), Blackwell Scientific Publishers, Oxford (1987).
2. BADAWI, A.F., HIRVONEN, A., BELL, D.A., LANG, N.P. and KADLUBAR, F.F., Role of aromatic amine acetyltransferases. NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55, 5230-5237 (1995).
3. BELL, D.A., TAYLOR, J.A., BUTLER, M.A., STEPHENS, E.A., WIEST, J., BRUBAKER, D.H., KADLUBAR, F.F. and LUCIER, G.W., Genotype/phenotype discordance for human N-acetyltransferase (NAT2) reveals a new slow acetylator allel common in African-Americans. Carcinogenesis, 14, 1689-1692 (1993).
4. BRÖCKMOLLER, J., KAISER, R., KERB, R., CASCORBI, I., JAEGER, V. and ROOTS, I., Polymorphic enzymes of xenobiotic metabolism as modulators of acquired p53 mutations in bladder cancer. Pharmacogenetics, 6, 535-545 (1996).
5. BRYANT, M.S., VINEIS, P., SKIPPER, P. and TANNENBAUM, S.R., Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc. nat. Acad. Sci. (Wash.), 85, 9788-9791 (1988).
6. CARTWRIGHT, R.A., AHMAD, R.A., BARHAM-HALL, D., GLASHAN, R.W., ROGERS, H.J., HICGINS, E. and KAHN, M.A., Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiologic approach to bladder cancer. Lancet, 2, 842-845 (1982).
7. CLAVEL, J., CORDIER, S., BOCCON-GIBOD, L. and HEMON, D., Tobacco and bladder cancer in males: increased risk for inhalers and black tobacco smokers. Int. J. Cancer, 44, 605-610 (1989).
8. CURIGLIANO, G., ZHANG, Y.J., WANG, L.Y., FLAMINI, G., ALCINI, A., RATTO, C., GIUSTACCHINI, M., ALCINI, E., CITTADINI, A. and SANTELLA, R.M., Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T 1 bladder cancer of smokers and nonsmokers. Carcinogenesis, 17, 911 -916 (1996).
9. D'AVANZO, B., NEGRI, E., LA VECCHIA, C., GRAMENZI, A., BIANCHI, C., FRANCESCHI, S. and BOYLE, P., Cigarette smoking and bladder cancer. Europ. J. Cancer, 26, 714-718 (1990).
10. D'ERRICO, A., TAIOLI, E., CHEN, X. and VINEIS, P., Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers, 1, 149-173 (1996).
11. ESRIG, D., SPRUCK, C.H. III, NICHOLS, P.W., CHAIWUN, B., STEVEN, K., GROSHEN, S., CHEN, S.C., SKINNER, D.G., JONES, P.A. and COLE, R.J., p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer. Am. J. Pathol., 143, 1389-1397 (1993).
12. ESTÈVE, A., SORLIE, T., MARTEL, PLANCHE, G., HOLLSTEIN, M., KUSTERS, I., LEWALTER, J. VINEIS, P., STEPHAN-ODENTHAL, M. and MONTESANO, R., Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors. J. Occup. Environ. Med., 37, 59-68 (1995).
13. EVANS, D.A.P., EZE, L.C. and WHIBLEY, E.J., The association of the slow acetylator phenotype with bladder cancer. J. Med. Genet., 20, 330-333 (1983).
14. FRYER, A.A., ZHAO, L., ALLDERSEA, J., PEARSON, W.R. and STRANGE, R.C., Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1A, GSTM1B, GSTM1A,B and GSTM1 null polymorphisms of the glutathione-S transferase GSTM1 locus. Biochem. J., 295, 313-315 (1993).
15. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor-suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
16. HEIN, D.W., Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta, 948, 37-66 (1988).
17. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38. Tobacco smoking, p. 270. IARC, Lyon (1986).
18. (ARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Suppl. 7: Overall evaluation of carcinogenicity: an updating of IARC monographs 1 to 42. IARC, Lyon (1987).
19. ISCOVICH, J., CASTELLETO, R., ESTÈVE, J., MUÑOZ, N., COLANZI, R., CORONEL, A., DEAMEZOLA, I., TASSI, V. and ARSLA, A., Tobacco smoking, occupational exposure, and bladder cancer in Argentina. Int. J. Cancer, 40, 734-740 (1987).
20. KADLUBAR, F.F., TALASKA, G., LANG, N.P., BENSON, R.W. and ROBERTS, D.W., Assessment of exposure and susceptibility to aromatic amine carcinogens. IARC Scientific Publication 89, 166-174 (1988).
21. LIN, D., LAY, O.J., BRYANT, M.S., MALAVEILLE, C., FRIESEN, M., BARTSCH, H., LANG, N.P. and KADLUBAR, F.F., Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ. Health Perspect., 102, 11-16 (1994).
22. MOMMSEN, S. and AAGAARD, J., Susceptibility in urinary bladder cancer: acetyltransferase phenotypes and related risk factors. Cancer Lett., 32, 199-205 (1986).
23. PATRIANAKOS, C. and HUFFMAN, D., Chemical studies of tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J. anal. Chem., 3, 150-154 (1979).
24. SCHULTE, P.A., The role of genetic factors in bladder cancer. Cancer Detect. Prev., 11, 379-388 (1988).
25. SKIPPER, P.L. and TANNENBAUM, S.R., Molecular dosimetry of aromatic amines in human populations. Environ. Health Perspect., 102 (Suppl. 6), 17-21 (1994).
26. TALASKA, G., AL-JUBURI, A.Z. and KADLUBAR, F.F., Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. nat. Acad. Sci (Wash.), 88, 5350-5354 (1991).
27. TAYLOR, J.A., LI, Y., MASON, T., METTLIN, C., VOGLER, W.J., MAYGARDEN, S. and LIU, E., p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res., 55, 294-298 (1996).
28. TOMKINS, B.A., BRAZELL, R.S., ROTH, M.E. and OSTRUM, V.H., Isolation of monitrated poiycyclic aromatic hydrocarbons in participate matter by liquid Chromatograph y and determination by gas chromatography with the termal energy analyzer. Anal. Chem., 56, 781-786 (1984).
29. VET, J.A.M., BRINGUIER, P.P., PODDIGHE, P.J., KARTHAUS, H.F.M., DEBRUYNE, F.M.J. and SCHALKEN, J.A., p53 mutations have no additional prognostic value over stage in bladder cancer, Br. Med. J., 70, 496-500 (1994).
30. VINEIS, P., BARTSCH, H., CAPORASO, N., HARRINGTON, A.M., KADLUBAR, F.F., LANDI, M.T., MALAVEILLE, C., SHIELDS, P., SKIPPER, P., TALASKA, G. and TANNENBAUM, S.R., Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature (Lond.), 369, 154-156 (1994).
31. VINEIS, P., CAPORASO, N., TANNENBAUM, S., SKIPPER, P., GLOGOWSKI, J., BARTSCH, H., CODA, M., TALASKA, G. and KADLUBAR, F., The acetylation phenotype. carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Res., 50, 3002-3004 (1990).
32. VINEIS, P., ESTÈVE, J., HARTGE, P., HOOVER, R., SILVERMAN, D.T. and TERRACINI, B., Effects of the timing and type of tobacco in cigarette-induced bladder cancer. Cancer Res., 48, 3849-3852 (1988).
33. YU, M.C., SKIPPER, P.L., TAGHIZADEH, K., TANNENBAUM, S.R., CHAN, K.K., HENDERSON, B.E. and ROSS, R.K., Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J. nat. Cancer Inst., 86, 712-716 (1994).